会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Ultrasonic angioplasty transmission member
    • 超声波血管成形术传播部件
    • US06494891B1
    • 2002-12-17
    • US09474953
    • 1999-12-30
    • Wayne E. CornishRobert C. EsselsteinSepehr FariabiHenry Nita
    • Wayne E. CornishRobert C. EsselsteinSepehr FariabiHenry Nita
    • A61B1732
    • A61B17/22012A61B2017/22015A61B2017/22018
    • The ultrasonic angioplasty transmission wire has regions of reduced cross-sectional diameter to improve flexibility of the ultrasonic angioplasty transmission wire and to compensate for degradation of longitudinal displacement due to acoustic losses along the length of the ultrasonic angioplasty transmission wire. One or more constraining members are disposed on the ultrasonic angioplasty transmission wire at one or more of the regions of reduced cross-sectional diameter where transverse vibration of ultrasonic energy transmitted by the ultrasound transmission wire is amplified, to constrain transverse vibration at these areas to reduce stress and reduce fracturing, while allowing longitudinal movement. The transmission wire has an elongated shaft including, in atomic percent, from about 28 to about 52 percent nickel, from about 48 to about 52 percent titanium, and up to about 20 percent of at least one alloying element selected from the group consisting of palladium, chromium, and hafnium.
    • 超声波血管成形术传输线具有减小的横截面直径的区域,以改善超声波血管成形术传输线的柔性,并且补偿由于沿着超声波血管成形术传输线的长度的声学损失引起的纵向位移的退化。 一个或多个约束构件设置在超声波血管成形术传输线上的一个或多个减小横截面直径的区域中,其中由超声波传输线传输的超声能量的横向振动被放大,以限制这些区域的横向振动,以减少 应力和减少压裂,同时允许纵向移动。 传输线具有细长轴,原子百分比包括约28至约52%的镍,约48至约52%的钛,以及至多一种选自钯的至少一种合金元素的至多约20% ,铬和铪。
    • 9. 发明授权
    • High strength member for intracorporeal use
    • 用于体内使用的高强度成员
    • US5636641A
    • 1997-06-10
    • US280209
    • 1994-07-25
    • Sepehr Fariabi
    • Sepehr Fariabi
    • A61F2/00A61F2/06A61F2/84A61M25/00A61M25/09A61B5/00
    • A61M25/0012A61F2/958A61M25/0009A61M25/09A61F2210/0019A61M2025/09083
    • This invention is directed to an intracorporeal device formed of a high strength Co--Ni--Cr alloy and is particularly suitable for forming a composite product with a pseudoelastic member formed of NiTi alloy. Suitable intracorporeal products include guidewires and stents. The high strength alloy consists essentially of about 28 to about 65% cobalt, about 2 to about 40% nickel, about 5 to about 35% chromium, up to about 12% molybdenum, up to about 20% tungsten, up to about 20% iron and the balance inconsequential amounts of impurities and other alloying constituents, with a preferred alloy composition including about 30 to about 45% cobalt, about 25 to about 37% nickel, about 15 to about 25% chromium and about 5 to about 15% molybdenum. Intravascular devices such as guidewires, stents and the like can be formed of this high strength Co--Ni--Cr alloy.
    • 本发明涉及由高强度Co-Ni-Cr合金形成的体内器件,特别适用于形成具有由NiTi合金形成的假弹性体的复合产品。 合适的体内产品包括导线和支架。 高强度合金主要由约28至约65%的钴,约2-约40%的镍,约5-35%的铬,至多约十二%的钼,至多约20%的钨,至多约20% 铁和余量是无关的量的杂质和其他合金成分,优选的合金组成包括约30至约45%的钴,约25至约37%的镍,约15至约25%的铬和约5至约15%的钼 。 诸如导线,支架等的血管内装置可以由这种高强度Co-Ni-Cr合金形成。